I was twenty-eight when my supervisor sat me down and asked a question that stopped me cold. “Have you thought about where you want to publish?” I had spent months revising my manuscript, obsessing over every comma and citation. But I had not given a single thought to which publisher我应该 target. I shrugged and said, “Does it matter? They’re all the same, right?” She laughed—not a kind laugh, but the laugh of someone who had been in this game for decades and had just heard a student say something spectacularly naive. “They are not the same,” she said. “Elsevier and Springer are the two giants of academic publishing. But they have very different personalities. And if you don’t understand that, you will waste months submitting to the wrong journals.” That sentence stayed with me. I realised that choosing between Elsevier and Springer was not just about picking a journal. It was about understanding two very different publishing philosophies, two very different costs, and two very different reputations. And it was about knowing which one aligned with my research, my career stage, and my values.
If you are looking for a detailed comparison to help you make this decision, Premier Dissertations offers a comprehensive guide on Elsevier vs Springer academic publishing. You can explore it here: https://premierdissertations.com/elsevier-vs-springer-academic-publishing-guide/. This guide breaks down the differences in cost, reputation, open access policies, and journal portfolios to help you choose the right path for your research.
The first thing I learned was just how massive both publishers are. In 2025, Elsevier generated an estimated $3.8 billion in scientific, technical, and medical publishing revenue from a portfolio exceeding 2,900 journals. Springer Nature followed with approximately $1.9 billion. In terms of journal count, Elsevier led with 1,552 SCIE journals, while Springer Nature had 1,289 SCIE journals. But size alone does not tell the whole story. The two publishers also lead the open access revolution. In 2025, Springer Nature surpassed MDPI to become the world’s largest open access publisher, with an OA publication output of 220,052 articles. Elsevier followed closely with 190,280 OA articles. Both publishers are investing heavily in open access, but they have taken different paths to get there.
The most significant difference between Elsevier and Springer is cost. In 2025, the average Article Processing Charge for open access journals was USD 3,094. But the two publishers sit at very different points on that spectrum. Springer Nature recorded the highest average APC among major hybrid OA publishers, at USD 3,836—exceeding the global average by nearly 24%. Elsevier’s average APC was USD 3,483, still above the global average but noticeably lower than Springer’s. Data from the University of Milan in the first half of 2025 confirmed this pattern: Springer Nature charged an average of €2,981 per article, while Elsevier charged €2,802. This difference may seem small, but it adds up across multiple publications. As one researcher noted, Springer Nature’s APCs have been rising faster than those of its competitors. For early-career researchers without dedicated funding, this cost difference can be decisive.
The reputation of the two publishers is also distinct. In a 2025 comparison of academic publishers, Elsevier scored 85 out of 100, while Springer Nature scored 76. Elsevier is widely regarded as the more prestigious and rigorously selective publisher, particularly in fields like medicine, life sciences, and engineering. It has also been praised for its low retraction rate and high rate of reinstating articles compared to other top publishers. Springer Nature, while highly respected, is seen as more accessible and broadly focused. Its portfolio includes the prestigious Nature family of journals, which are among the most selective in the world, but also a vast array of other journals that range from highly selective to relatively open.
The open access policies of the two publishers reflect their different approaches to the publishing landscape. Elsevier typically offers hybrid open access options, where authors can pay to make individual articles open access within subscription journals. Springer Nature, by contrast, has pursued a more aggressive open access strategy, becoming the largest OA publisher in 2025. But this scale has not come without criticism. Springer Nature’s APCs are among the highest in the industry, and its transformative agreements with institutions have been described as complex and sometimes challenging to navigate. For researchers at institutions with limited funding, this can create barriers to publishing in Springer Nature’s journals.
The sheer scale of both publishers has broader implications for the academic community. The top five publishers—Elsevier, Springer Nature, Wiley, Taylor & Francis, and SAGE—collectively account for roughly half or more of journal output and revenue. This concentration of power has raised concerns about rising costs, limited access, and the influence of commercial interests on academic publishing. Yet both Elsevier and Springer Nature have also made significant contributions to the global research infrastructure. They have developed sophisticated author services, including language editing, formatting, and submission support. They have invested in research integrity tools and initiatives. And they have played a central role in the transition to open access, even if that transition has come with significant costs.
I eventually published with both publishers. My first article went to an Elsevier journal—a decision driven by my supervisor’s advice and the journal’s strong reputation in my field. The review process was thorough and took nearly five months. The reviewers were demanding, and I had to revise extensively. But the final publication felt earned. My second article went to a Springer Nature journal—a decision driven by the journal’s open access policy and my need to meet a funding deadline. The process was faster, the reviewers were less demanding, and the publication appeared within two months. Both experiences were positive, but they were different. The Elsevier experience was more rigorous and more time-consuming. The Springer Nature experience was more efficient and more accessible. Neither was better or worse. They were just different.
If you are considering publishing with Elsevier or Springer Nature, here is my advice. First, look at your field. Some disciplines favour one publisher over the other. Talk to your supervisor and colleagues. Second, look at your funding. If you have limited resources, the lower APCs of Elsevier may be more attractive. If you have institutional support through a transformative agreement, Springer Nature may offer more options. Third, look at the specific journal, not just the publisher. Both Elsevier and Springer Nature publish journals across the full spectrum of quality. A top-tier Elsevier journal and a top-tier Springer Nature journal are both excellent. A lower-tier journal from either publisher may be less competitive. Fourth, read recent articles from the journals you are considering. Understand their style, their expectations, and their audience. Fifth, check the journal’s indexing. Both publishers have journals indexed in Scopus and Web of Science, but not all of them are. Sixth, and most importantly, do not pay for a guaranteed publication. Whether you publish with Elsevier or Springer Nature, the research you have worked so hard on deserves to be published in a journal that respects the integrity of the peer review process.
The publication journey taught me something I will never forget. There is no single right answer when choosing between Elsevier and Springer Nature. The right choice depends on your field, your career stage, your funding situation, and your personal values. Both are legitimate, respected, and essential to the global research ecosystem. But they are not interchangeable. They have different costs, different reputations, different open access policies, and different personalities. The key is to understand those differences and make an informed choice. The research you have worked so hard on deserves nothing less.